HESPEROS, INC: Expanded implementation of a human-based Malaria-on-a-Chip phenotypic disease model for the evaluation of therapeutic efficacy and off-target toxicity
HESPEROS, INC (Orlando, Florida): Expanded implementation of a human-based Malaria-on-a-Chip phenotypic disease model for the evaluation of therapeutic efficacy and off-target toxicity. Its award of $1,000,000 is above the median of $407,048 (87th percentile). Dated 68 days ago, it serves as a historical benchmark. Score 70/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
award: $1,000,000 · 87th percentile of 10,712 NihBiotechGrantPulse records · 2.5x the median
Free preview: all 10 published fields of this record are shown below. Locked: 314 related FL NihBiotechGrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Organization | HESPEROS, INC |
| Location | ORLANDO, FL |
| Project | Expanded implementation of a human-based Malaria-on-a-Chip phenotypic disease model for the evaluation of therapeutic efficacy and off-target toxicity |
| Project number | 1R44AI197758-01 |
| Mechanism | R44 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $1,000,000 |
| Awarded | 2026-08-28 |
| Project period | 2026-09-01 to 2028-08-31 |
| UEI | R1LSLA5YJMJ9 |
| award percentile | 87th of 10,712 (median $407,048, 2.5x median) |
| Peer records CSV (315 FL records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch HESPEROS, INC
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of FL records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock HESPEROS + all 315 FL records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL
- Source agency: NIH RePORTER (newly awarded projects)
- Record date: 2026-08-28
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top NihBiotechGrantPulse records (FL first): UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · MYOSIN THERAPEUTICS INC. · UNIVERSITY OF FLORIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · UNIVERSITY OF FLORIDA · Browse all by state and category →
LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: HESPEROS, INC and 315 Florida peers
- Florida NihBiotechGrantPulse records like this one: 315
- HESPEROS, INC's award: 87th percentile of 10,712 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every Florida peer: $63,000 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
70 / 100 Lab Budget Score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.
What is the NihBiotechGrantPulse record for HESPEROS, INC in Orlando, Florida?
HESPEROS, INC received an NIH award of $1,000,000 on 2026-08-28: Expanded implementation of a human-based Malaria-on-a-Chip phenotypic disease model for the evaluation of therapeutic efficacy and off-target toxicity.
How does HESPEROS, INC compare to other Florida NihBiotechGrantPulse records?
Its award of $1,000,000 sits in the upper half (87th percentile) of 10,712 records; the median is $407,048. It is 68 days old; check the official source for later updates before acting. Its Lab Budget Score of 70/100 puts it among the stronger signals in this feed.
HESPEROS, INC vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| HESPEROS, INC | ORLANDO, FL | 1,000,000 | 87th | 2026-08-28 |
| IONCOLOGI INC | GAINESVILLE, FL | 1,006,593 | 87th | 2026-09-17 |
| VIGILANT LABORATORIES LLC | PINECREST, FL | 1,019,384 | 87th | 2026-09-17 |
| BOLD TYPE LLC | ORLANDO, FL | 1,090,128 | 89th | 2026-09-17 |
Related records
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- UNIVERSITY OF FLORIDA
- IONCOLOGI INC
- I-FUNCTION, INC.
- VIGILANT LABORATORIES LLC
- MYOSIN THERAPEUTICS INC.
- BOLD TYPE LLC
- H. LEE MOFFITT CANCER CTR & RES INST
- UNIVERSITY OF FLORIDA
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- UNIVERSITY OF FLORIDA
NihBiotechGrantPulse: records in Florida NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)
More Florida public-record feeds
New FDA Medical Device Listings by Manufacturer, CMO & Sterilizer in Florida New, Terminating & Large 401(k) Plans from Form 5500 Filings in Florida School & Library E-Rate Contracts Up for Rebid in Florida SEC 8-K Corporate Trigger Events in Florida Credit Union Quarterly Changes, Mergers & New Charters (NCUA Call Reports) in Florida New MSHA Citations at Mines & Quarries by State in Florida HIPAA Breach Reports (500+ Individuals) by State & Type in Florida FEMA Hazard Mitigation Project Tracker in Florida
How to monitor HESPEROS, INC and peer small business sbir/sttr (r41-r44, u43-u44) records
Get new NihBiotechGrantPulse records like HESPEROS, INC by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.